P021
Also called P21
No single human route established in this referenceAnimal / laboratory reference
Research reference
Animal / laboratory study
P021 Alzheimer-model prevention experiment
Experimental P021 exposure in mice, not a human course
Mouse disease-prevention observations
P021 primary mouse study (2017) ↗When results may show
P021
Evidence gap- When change was measured
- Dendritic/synaptic and cognitive findings in mice do not supply a human onset or prevention claim. P021 is not the p21 cell-cycle protein.
- When to assess
- Mouse disease-prevention observations
- Conditions and limitations
- Triple-transgenic Alzheimer-model mice. No human starting amount, course length, cycling, mixing volume or time-to-result is established by this experiment.
- When to stop
- The measured study window is not a validated personal quit rule. Do not increase or prolong exposure because an expected result is absent; severe or persistent reactions need prompt clinical review.
Sources: P021 primary mouse study (2017)
Research timing is descriptive, not a promise or personal instruction. A severe or persistent reaction needs prompt clinical review. This is not medical advice.
Modelled level — every day
1× is the peak after a single dose.
- Steady-state peak
- 1.07× single dose
- Time to steady state
- 30hours
- Administrations
- 7/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- P021 primary mouse study (2017)No human starting amount, course length, cycling, mixing volume or time-to-result is established by this experiment.